A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma

S Nicholson, K Guile, J John, I A Clarke, J Diffley, P Donnellan, A Michael, P Szlosarek, A G Dalgleish

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma'. Together they form a unique fingerprint.

    Medicine & Life Sciences